154 related articles for article (PubMed ID: 33274278)
21. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
[TBL] [Abstract][Full Text] [Related]
22. Probing Endosomal Escape Using pHlexi Nanoparticles.
Kongkatigumjorn N; Cortez-Jugo C; Czuba E; Wong AS; Hodgetts RY; Johnston AP; Such GK
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27786422
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid inducible gene-I mediated detection of bacterial nucleic acids in human microglial cells.
Johnson MB; Halman JR; Burmeister AR; Currin S; Khisamutdinov EF; Afonin KA; Marriott I
J Neuroinflammation; 2020 May; 17(1):139. PubMed ID: 32357908
[TBL] [Abstract][Full Text] [Related]
24. Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction.
Liu G; Park HS; Pyo HM; Liu Q; Zhou Y
J Virol; 2015 Jun; 89(11):6067-79. PubMed ID: 25810557
[TBL] [Abstract][Full Text] [Related]
25. Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.
Kilchrist KV; Dimobi SC; Jackson MA; Evans BC; Werfel TA; Dailing EA; Bedingfield SK; Kelly IB; Duvall CL
ACS Nano; 2019 Feb; 13(2):1136-1152. PubMed ID: 30629431
[TBL] [Abstract][Full Text] [Related]
26. Selection of molecular structure and delivery of RNA oligonucleotides to activate TLR7 versus TLR8 and to induce high amounts of IL-12p70 in primary human monocytes.
Ablasser A; Poeck H; Anz D; Berger M; Schlee M; Kim S; Bourquin C; Goutagny N; Jiang Z; Fitzgerald KA; Rothenfusser S; Endres S; Hartmann G; Hornung V
J Immunol; 2009 Jun; 182(11):6824-33. PubMed ID: 19454678
[TBL] [Abstract][Full Text] [Related]
27. Rational design of composition and activity correlations for pH-responsive and glutathione-reactive polymer therapeutics.
El-Sayed ME; Hoffman AS; Stayton PS
J Control Release; 2005 May; 104(2):417-27. PubMed ID: 15984055
[TBL] [Abstract][Full Text] [Related]
28. Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery.
Hendershot J; Smith AE; Werfel TA
J Vis Exp; 2019 May; (147):. PubMed ID: 31107463
[TBL] [Abstract][Full Text] [Related]
29. Rational design of composition and activity correlations for pH-sensitive and glutathione-reactive polymer therapeutics.
El-Sayed ME; Hoffman AS; Stayton PS
J Control Release; 2005 Jan; 101(1-3):47-58. PubMed ID: 15588893
[TBL] [Abstract][Full Text] [Related]
30. RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing Cytotoxicity.
Ho V; Yong HY; Chevrier M; Narang V; Lum J; Toh YX; Lee B; Chen J; Tan EY; Luo D; Fink K
J Virol; 2019 Jul; 93(14):. PubMed ID: 31043531
[TBL] [Abstract][Full Text] [Related]
31. Dependence of RIG-I Nucleic Acid-Binding and ATP Hydrolysis on Activation of Type I Interferon Response.
Baek YM; Yoon S; Hwang YE; Kim DE
Immune Netw; 2016 Aug; 16(4):249-55. PubMed ID: 27574504
[TBL] [Abstract][Full Text] [Related]
32. Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery.
Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP
Biomacromolecules; 2013 Nov; 14(11):4135-49. PubMed ID: 24125032
[TBL] [Abstract][Full Text] [Related]
33. One-Pot Synthesis of pH/Redox Responsive Polymeric Prodrug and Fabrication of Shell Cross-Linked Prodrug Micelles for Antitumor Drug Transportation.
Li L; Li D; Zhang M; He J; Liu J; Ni P
Bioconjug Chem; 2018 Aug; 29(8):2806-2817. PubMed ID: 30005157
[TBL] [Abstract][Full Text] [Related]
34. Approaching the RNA ligand for RIG-I?
Schlee M; Hartmann E; Coch C; Wimmenauer V; Janke M; Barchet W; Hartmann G
Immunol Rev; 2009 Jan; 227(1):66-74. PubMed ID: 19120476
[TBL] [Abstract][Full Text] [Related]
35. Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.
Xu J; Mercado-López X; Grier JT; Kim WK; Chun LF; Irvine EB; Del Toro Duany Y; Kell A; Hur S; Gale M; Raj A; López CB
mBio; 2015 Oct; 6(5):e01265-15. PubMed ID: 26443454
[TBL] [Abstract][Full Text] [Related]
36. pH-Responsive Amphiphilic Carboxylate Polymers: Design and Potential for Endosomal Escape.
Wang S
Front Chem; 2021; 9():645297. PubMed ID: 33834015
[TBL] [Abstract][Full Text] [Related]
37. Enhanced Performance of Plasmid DNA Polyplexes Stabilized by a Combination of Core Hydrophobicity and Surface PEGylation.
Adolph EJ; Nelson CE; Werfel TA; Guo R; Davidson JM; Guelcher SA; Duvall CL
J Mater Chem B; 2014 Dec; 2(46):8154-8164. PubMed ID: 25530856
[TBL] [Abstract][Full Text] [Related]
38. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics.
Gu L; Faig A; Abdelhamid D; Uhrich K
Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069
[TBL] [Abstract][Full Text] [Related]
39. An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation.
Castiello L; Zevini A; Vulpis E; Muscolini M; Ferrari M; Palermo E; Peruzzi G; Krapp C; Jakobsen M; Olagnier D; Zingoni A; Santoni A; Hiscott J
Cancer Immunol Immunother; 2019 Sep; 68(9):1479-1492. PubMed ID: 31463653
[TBL] [Abstract][Full Text] [Related]
40. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
Hafner AM; Corthésy B; Merkle HP
Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
